InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,528.80
(
0.90%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
73.04
(
-1.32%
)
Bitcoin
69,363.71
(
-1.20%
)
Post# of 21544
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

XenaLives

Send PM Follow Ignore
Followers 482
Posts 61673
Boards Moderated 14
Alias Born 09/20/2001

XenaLives

Member Level

Re: InTheTrenches post# 9395

Monday, 04/01/2019 3:41:45 PM

Monday, April 01, 2019 3:41:45 PM

Post# of 21544
Um.. both Anavex and Neurotrope are in phase two.

There is no "hands down" anything at this point.

Neurotrope has a placebo P2 which is not required in a safety trial.

Anavex has five years of safety data.

Anavex has two trials reading out this year which will give additional data. The largest trial, in Parkinson's dementia, has had investigators requesting to extend the trial before it is fully enrolled. Something must be going on. This is a placebo controlled trial. If investigators are seeing results so obvious that they believe the trial needs to be extened the placebo is moot and the P2a in Alzheimer's is corroborated.

The results from the Parkinson's trial could be strong enough for Anavex to gain provisional approval in Australia before the end of the year.





In Peace, In War

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SNPX News
More SNPX News
InvestorsHub NewsWire

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM

Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM

CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM

Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM

Start posting your company's news
Only $200 per official company press release!